TESTBANK m,u
Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
m,u m,u m,u m,u m,u m,u m,u
Author: Teri Moser Woo and Wendy L. Wright
m,u m,u m,u m,u m,u m,u m,u
, TABLE OF CONTENT m,u m,u
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber .......................................................................... 4
m,u m,u m,u m,u m,u m,u m,u m,u m,u m,u
Chapter 2. Review of Basic Principles of Pharmacology......................................................................................... 5
m,u m,u m,u m,u m,u m,u m,u
Chapter 3. Rational Drug Selection ...................................................................................................................... 11
m,u m,u m,u m,u
Chapter 4. Legal and Professional Issues in Prescribing ........................................................................................ 14
m,u m,u m,u m,u m,u m,u m,u
Chapter 5. Adverse Drug Reactions ...................................................................................................................... 16
m,u m,u m,u m ,u
Chapter 6. An Introduction to Pharmacogenomics ................................................................................................ 19
m,u m,u m,u m,u m,u
Chapter 7. Nutrition and Nutraceuticals................................................................................................................ 22
m,u m,u m,u m,u
Chapter 8. Herbal Therapies ................................................................................................................................. 28
m,u m,u m,u
Chapter 9. Cannabis ............................................................................................................................................. 31
m,u m,u
Chapter 10. Pharmacoeconomics ......................................................................................................................... 35
m,u m,u
Chapter 11. Drugs Affecting the Autonomic Nervous System .............................................................................. 38
m,u m,u m,u m,u m,u m,u m,u
Chapter 12. Drugs Affecting the Central Nervous System .................................................................................... 45
m,u m,u m,u m,u m,u m,u m,u
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems .................................................................... 53
m,u m,u m,u m,u m,u m,u m,u m,u
Chapter 14. Drugs Affecting the Respiratory System............................................................................................ 61
m,u m,u m,u m,u m,u m,u
Chapter 15. Drugs Affecting the Hematological System ....................................................................................... 65
m,u m,u m,u m,u m,u m,u
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins .............................................. 69
m,u m,u m,u m,u m,u m,u m,u m,u m,u
Chapter 17. Drugs Affecting the Immune System: Immunomodulators ................................................................ 75
m,u m,u m,u m,u m,u m,u m,u
Chapter 18. Drugs Affecting the Gastrointestinal System ..................................................................................... 77
m,u m,u m,u m,u m,u m,u
Chapter19. DrugsAffecting the EndocrineSystem: Pancreatic Hormones and Antidiabetic Drugs ......................... 80
m
,u m,u m
,u m,u m,u m
,u m,u m
,u m
,u m,u m,u
Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ................................. 83
m,u m,u m,u m,u m,u m,u m,u m,u m,u m,u m,u
Chapter 21. Drugs Affecting the Reproductive System ......................................................................................... 86
m,u m,u m,u m,u m,u m,u
Chapter 22. Drugs Affecting the Bones and Joints ................................................................................................ 92
m,u m,u m,u m,u m,u m,u m,u
Chapter 23. Drugs Affecting the Integumentary System ....................................................................................... 96
m,u m,u m,u m,u m,u m,u
Chapter 24. Drugs Used to Treat Bacterial Infections .......................................................................................... 101
m,u m,u m,u m,u m,u m,u m,u
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections ............................................................ 105
m,u m,u m,u m,u m,u m,u m,u m,u m,u m ,u
Chapter 26. Drugs Used to Treat Inflammatory Processes................................................................................... 108
m,u m,u m,u m,u m,u m,u m,u
Chapter 27. Drugs Used to Treat Eye and Ear Disorders ...................................................................................... 111
m,u m,u m,u m,u m,u m,u m,u m,u m,u
Chapter 28. Anemia ........................................................................................................................................... 113
m,u m,u
Chapter 29. Anxiety and Depression .................................................................................................................. 116
m,u m,u m,u m,u
Chapter 30. Attention Deficit-Hyperactivity Disorder........................................................................................ 120
m,u m,u m,u m,u
Chapter 31. Asthma and Allergy ........................................................................................................................ 122
m,u m,u m,u m ,u
Chapter 32. Chronic Obstructive Pulmonary Disease ......................................................................................... 125
m,u m,u m,u m,u m,u
Chapter 33. Contraception .................................................................................................................................. 127
m,u m,u
Chapter 34. COVID-19: Acute and Chronic ....................................................................................................... 130
m,u m,u m,u m,u m,u
Chapter 35. Dermatological Conditions ............................................................................................................. 134
m,u m,u m,u
Chapter 36. Diabetes Management ..................................................................................................................... 138
m,u m,u m,u
Chapter 37. Gastroesophageal Reflux and Peptic Ulcer Disease ......................................................................... 146
m,u m,u m,u m,u m,u m,u m,u
Chapter 38. Headaches ....................................................................................................................................... 149
m,u m,u
Chapter 39. Heart Failure ................................................................................................................................... 153
m,u m,u m,u
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome ............................................................... 158
m,u m,u m,u m,u m,u m,u m,u
Chapter 41. Menopausal Hormone Therapy ....................................................................................................... 161
m,u m,u m,u m,u
,Chapter 42. Hyperlipidemia ............................................................................................................................... 164
m,u m,u
Chapter 43. Hypertension ................................................................................................................................... 169
m,u m,u
Chapter 44. Hyperthyroidism and Hypothyroidism ............................................................................................ 174
m,u m,u m,u m,u
Chapter 45. Obesity ............................................................................................................................................ 177
m,u m,u
Chapter 46. Pain Management: Acute and Chronic Pain ..................................................................................... 181
m,u m,u m,u m,u m,u m,u m,u
Chapter 47. Pneumonia ...................................................................................................................................... 185
m,u m,u
Chapter 48. Sexually Transmitted Diseases and Vaginitis................................................................................... 187
m,u m,u m,u m,u m,u m,u
Chapter 49. Substance Use Disorders ................................................................................................................. 190
m,u m,u m,u m,u
Chapter 50. Tuberculosis.................................................................................................................................... 195
m,u m,u
Chapter51.Upper Respiratory Tract Infection, Pharyngitis, Sinusitis,Otitis Media, and Otitis Externa................. 197
m
,u m
,u m,u m,u m,u m,u m,u m
,u m,u m,u m,u m,u
Chapter 52. Urinary Tract Infections .................................................................................................................. 200
m,u m,u m,u m,u
Chapter 53. Women as Patients .......................................................................................................................... 203
m,u m,u m,u m,u
Chapter 54. Men as Patients ................................................................................................................................ 207
m,u m,u m,u m,u
Chapter 55. Pediatric Patients ............................................................................................................................. 209
m,u m,u m,u
Chapter 57. Geriatric Patients ............................................................................................................................. 213
m,u m,u m,u
, Woo 1
PharmacotherapeuticsforAPN Prescribers, 6e m
,u m
,u m,u m,u Ch01
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
m,u m,u m,u m,u m,u m,u m,u m,u m,u m,u
MULTIPLE CHOICE m,u
1. Nurse practitioner prescriptive authority is regulated by:
m,u m,u m,u m,u m,u m,u
A. The National Council of State Boards of Nursing m,u m,u m,u m,u m,u m,u m,u
B. The U.S. Drug Enforcement Administration m,u m,u m,u m,u
C. The State Board of Nursing for each state m,u m,u m,u m,u m,u m,u m,u
D. The State Board of Pharmacy m,u m,u m,u m,u
ANS: m , u C PTS: m , u m , u 1
2. Thebenefits to thepatient ofhaving an advanced practice registered nurse (APRN)prescriber
m
,u m,u m,u m
,u m,u m
,u m,u m,u m,u m,u m,u m,u m
,u
m,u include:
A. Nursesknowmore about pharmacology thanother prescribersbecause they takeit both
m
,u m
,u m,u m,u m,u m,u m,u m
,u m
,u m,u m
,u m,u
in their basic nursing program and in their APRN program.
m,u m,u m,u m,u m,u m,u m,u m,u m,u m,u
B. Nurses care for thepatient from a holistic approach and includethepatient in
m,u m,u m,u m
,u m,u m,u m,u m,u m,u m,u m
,u m
,u m,u
decision-making regarding their care.
m,u m,u m,u m,u
C. APRNs are less likely to prescribe narcotics and other controlledsubstances. m,u m,u m,u m,u m,u m,u m,u m,u m,u ,u
m
D. APRNs areabletoprescribeindependently in all states, whereas aphysician’s m,u m
,u m
,u m
,u m
,u m,u m,u m,u m,u m,u m
,u
assistant needs to have a physician supervising their practice.
m,u m,u m,u m,u m,u m,u m,u m,u m,u
ANS: m , u B PTS: m , u m , u 1
3. Clinical judgment in prescribing includes: m,u m,u m,u m,u
A. Factoring in the cost to the patient of the medication prescribed m,u m,u m,u m,u m,u m,u m,u m,u m,u m,u
B. Always prescribing the newest medication available for the diseaseprocess m,u m,u m,u m,u m,u m,u m,u m,u ,u
m
C. Handing out drug samples to poor patients m,u m,u m,u m,u m,u m,u
D. Prescribing all generic medications to cutcosts m,u m,u m,u m,u m,u m
,u
ANS: m , u A PTS: m , u m , u 1
4. The process for choosing an effective drug for a disorder includes:
m,u m,u m,u m ,u m,u m,u m,u m,u m,u m
,u
A. Asking the patient what drug they think would work best for them m,u m,u m,u m ,u m,u m,u m,u m,u m,u m,u m,u
B. Consulting nationally recognized guidelines for diseasemanagement m,u m,u m,u m,u m,u ,u
m
C. Prescribing medications that are available as samples before writing a prescription m,u m,u m,u m,u m,u m,u m,u m,u m,u m,u
D. Following U.S. Drug Enforcement Administration guidelines forprescribing m,u m,u m,u m,u m,u m,u ,u
m
ANS: m , u B PTS: m , u m , u 1
5. Nonintentional nonadherence of drug therapy may occur due to: m,u m,u m,u m,u m,u m,u m,u m,u
A. Belief that medication does not work m,u m,u m,u m,u m,u
B. Adverse drug reactions m,u m,u
C. Chronic conditions that require dailytherapy m,u m,u m,u m,u m
,u
D. Forgetfulness ordistraction m,u ,u
m
ANS: m , u D PTS: m , u m , u 1
Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
m,u m,u m,u m,u m,u m,u m,u
Author: Teri Moser Woo and Wendy L. Wright
m,u m,u m,u m,u m,u m,u m,u
, TABLE OF CONTENT m,u m,u
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber .......................................................................... 4
m,u m,u m,u m,u m,u m,u m,u m,u m,u m,u
Chapter 2. Review of Basic Principles of Pharmacology......................................................................................... 5
m,u m,u m,u m,u m,u m,u m,u
Chapter 3. Rational Drug Selection ...................................................................................................................... 11
m,u m,u m,u m,u
Chapter 4. Legal and Professional Issues in Prescribing ........................................................................................ 14
m,u m,u m,u m,u m,u m,u m,u
Chapter 5. Adverse Drug Reactions ...................................................................................................................... 16
m,u m,u m,u m ,u
Chapter 6. An Introduction to Pharmacogenomics ................................................................................................ 19
m,u m,u m,u m,u m,u
Chapter 7. Nutrition and Nutraceuticals................................................................................................................ 22
m,u m,u m,u m,u
Chapter 8. Herbal Therapies ................................................................................................................................. 28
m,u m,u m,u
Chapter 9. Cannabis ............................................................................................................................................. 31
m,u m,u
Chapter 10. Pharmacoeconomics ......................................................................................................................... 35
m,u m,u
Chapter 11. Drugs Affecting the Autonomic Nervous System .............................................................................. 38
m,u m,u m,u m,u m,u m,u m,u
Chapter 12. Drugs Affecting the Central Nervous System .................................................................................... 45
m,u m,u m,u m,u m,u m,u m,u
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems .................................................................... 53
m,u m,u m,u m,u m,u m,u m,u m,u
Chapter 14. Drugs Affecting the Respiratory System............................................................................................ 61
m,u m,u m,u m,u m,u m,u
Chapter 15. Drugs Affecting the Hematological System ....................................................................................... 65
m,u m,u m,u m,u m,u m,u
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins .............................................. 69
m,u m,u m,u m,u m,u m,u m,u m,u m,u
Chapter 17. Drugs Affecting the Immune System: Immunomodulators ................................................................ 75
m,u m,u m,u m,u m,u m,u m,u
Chapter 18. Drugs Affecting the Gastrointestinal System ..................................................................................... 77
m,u m,u m,u m,u m,u m,u
Chapter19. DrugsAffecting the EndocrineSystem: Pancreatic Hormones and Antidiabetic Drugs ......................... 80
m
,u m,u m
,u m,u m,u m
,u m,u m
,u m
,u m,u m,u
Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ................................. 83
m,u m,u m,u m,u m,u m,u m,u m,u m,u m,u m,u
Chapter 21. Drugs Affecting the Reproductive System ......................................................................................... 86
m,u m,u m,u m,u m,u m,u
Chapter 22. Drugs Affecting the Bones and Joints ................................................................................................ 92
m,u m,u m,u m,u m,u m,u m,u
Chapter 23. Drugs Affecting the Integumentary System ....................................................................................... 96
m,u m,u m,u m,u m,u m,u
Chapter 24. Drugs Used to Treat Bacterial Infections .......................................................................................... 101
m,u m,u m,u m,u m,u m,u m,u
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections ............................................................ 105
m,u m,u m,u m,u m,u m,u m,u m,u m,u m ,u
Chapter 26. Drugs Used to Treat Inflammatory Processes................................................................................... 108
m,u m,u m,u m,u m,u m,u m,u
Chapter 27. Drugs Used to Treat Eye and Ear Disorders ...................................................................................... 111
m,u m,u m,u m,u m,u m,u m,u m,u m,u
Chapter 28. Anemia ........................................................................................................................................... 113
m,u m,u
Chapter 29. Anxiety and Depression .................................................................................................................. 116
m,u m,u m,u m,u
Chapter 30. Attention Deficit-Hyperactivity Disorder........................................................................................ 120
m,u m,u m,u m,u
Chapter 31. Asthma and Allergy ........................................................................................................................ 122
m,u m,u m,u m ,u
Chapter 32. Chronic Obstructive Pulmonary Disease ......................................................................................... 125
m,u m,u m,u m,u m,u
Chapter 33. Contraception .................................................................................................................................. 127
m,u m,u
Chapter 34. COVID-19: Acute and Chronic ....................................................................................................... 130
m,u m,u m,u m,u m,u
Chapter 35. Dermatological Conditions ............................................................................................................. 134
m,u m,u m,u
Chapter 36. Diabetes Management ..................................................................................................................... 138
m,u m,u m,u
Chapter 37. Gastroesophageal Reflux and Peptic Ulcer Disease ......................................................................... 146
m,u m,u m,u m,u m,u m,u m,u
Chapter 38. Headaches ....................................................................................................................................... 149
m,u m,u
Chapter 39. Heart Failure ................................................................................................................................... 153
m,u m,u m,u
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome ............................................................... 158
m,u m,u m,u m,u m,u m,u m,u
Chapter 41. Menopausal Hormone Therapy ....................................................................................................... 161
m,u m,u m,u m,u
,Chapter 42. Hyperlipidemia ............................................................................................................................... 164
m,u m,u
Chapter 43. Hypertension ................................................................................................................................... 169
m,u m,u
Chapter 44. Hyperthyroidism and Hypothyroidism ............................................................................................ 174
m,u m,u m,u m,u
Chapter 45. Obesity ............................................................................................................................................ 177
m,u m,u
Chapter 46. Pain Management: Acute and Chronic Pain ..................................................................................... 181
m,u m,u m,u m,u m,u m,u m,u
Chapter 47. Pneumonia ...................................................................................................................................... 185
m,u m,u
Chapter 48. Sexually Transmitted Diseases and Vaginitis................................................................................... 187
m,u m,u m,u m,u m,u m,u
Chapter 49. Substance Use Disorders ................................................................................................................. 190
m,u m,u m,u m,u
Chapter 50. Tuberculosis.................................................................................................................................... 195
m,u m,u
Chapter51.Upper Respiratory Tract Infection, Pharyngitis, Sinusitis,Otitis Media, and Otitis Externa................. 197
m
,u m
,u m,u m,u m,u m,u m,u m
,u m,u m,u m,u m,u
Chapter 52. Urinary Tract Infections .................................................................................................................. 200
m,u m,u m,u m,u
Chapter 53. Women as Patients .......................................................................................................................... 203
m,u m,u m,u m,u
Chapter 54. Men as Patients ................................................................................................................................ 207
m,u m,u m,u m,u
Chapter 55. Pediatric Patients ............................................................................................................................. 209
m,u m,u m,u
Chapter 57. Geriatric Patients ............................................................................................................................. 213
m,u m,u m,u
, Woo 1
PharmacotherapeuticsforAPN Prescribers, 6e m
,u m
,u m,u m,u Ch01
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
m,u m,u m,u m,u m,u m,u m,u m,u m,u m,u
MULTIPLE CHOICE m,u
1. Nurse practitioner prescriptive authority is regulated by:
m,u m,u m,u m,u m,u m,u
A. The National Council of State Boards of Nursing m,u m,u m,u m,u m,u m,u m,u
B. The U.S. Drug Enforcement Administration m,u m,u m,u m,u
C. The State Board of Nursing for each state m,u m,u m,u m,u m,u m,u m,u
D. The State Board of Pharmacy m,u m,u m,u m,u
ANS: m , u C PTS: m , u m , u 1
2. Thebenefits to thepatient ofhaving an advanced practice registered nurse (APRN)prescriber
m
,u m,u m,u m
,u m,u m
,u m,u m,u m,u m,u m,u m,u m
,u
m,u include:
A. Nursesknowmore about pharmacology thanother prescribersbecause they takeit both
m
,u m
,u m,u m,u m,u m,u m,u m
,u m
,u m,u m
,u m,u
in their basic nursing program and in their APRN program.
m,u m,u m,u m,u m,u m,u m,u m,u m,u m,u
B. Nurses care for thepatient from a holistic approach and includethepatient in
m,u m,u m,u m
,u m,u m,u m,u m,u m,u m,u m
,u m
,u m,u
decision-making regarding their care.
m,u m,u m,u m,u
C. APRNs are less likely to prescribe narcotics and other controlledsubstances. m,u m,u m,u m,u m,u m,u m,u m,u m,u ,u
m
D. APRNs areabletoprescribeindependently in all states, whereas aphysician’s m,u m
,u m
,u m
,u m
,u m,u m,u m,u m,u m,u m
,u
assistant needs to have a physician supervising their practice.
m,u m,u m,u m,u m,u m,u m,u m,u m,u
ANS: m , u B PTS: m , u m , u 1
3. Clinical judgment in prescribing includes: m,u m,u m,u m,u
A. Factoring in the cost to the patient of the medication prescribed m,u m,u m,u m,u m,u m,u m,u m,u m,u m,u
B. Always prescribing the newest medication available for the diseaseprocess m,u m,u m,u m,u m,u m,u m,u m,u ,u
m
C. Handing out drug samples to poor patients m,u m,u m,u m,u m,u m,u
D. Prescribing all generic medications to cutcosts m,u m,u m,u m,u m,u m
,u
ANS: m , u A PTS: m , u m , u 1
4. The process for choosing an effective drug for a disorder includes:
m,u m,u m,u m ,u m,u m,u m,u m,u m,u m
,u
A. Asking the patient what drug they think would work best for them m,u m,u m,u m ,u m,u m,u m,u m,u m,u m,u m,u
B. Consulting nationally recognized guidelines for diseasemanagement m,u m,u m,u m,u m,u ,u
m
C. Prescribing medications that are available as samples before writing a prescription m,u m,u m,u m,u m,u m,u m,u m,u m,u m,u
D. Following U.S. Drug Enforcement Administration guidelines forprescribing m,u m,u m,u m,u m,u m,u ,u
m
ANS: m , u B PTS: m , u m , u 1
5. Nonintentional nonadherence of drug therapy may occur due to: m,u m,u m,u m,u m,u m,u m,u m,u
A. Belief that medication does not work m,u m,u m,u m,u m,u
B. Adverse drug reactions m,u m,u
C. Chronic conditions that require dailytherapy m,u m,u m,u m,u m
,u
D. Forgetfulness ordistraction m,u ,u
m
ANS: m , u D PTS: m , u m , u 1
